Meta Platforms delivered a stronger-than-expected quarter, fueled by robust advertising revenue and user growth. However, the company's sharply rising expense forecasts for AI and infrastructure investments are drawing increased analyst attention.
Hilltop Holdings (HTH) delivered a strong fourth-quarter performance, beating earnings estimates and announcing an 11% dividend increase alongside a new $125 million share repurchase program, fueling a rally in its stock price.
KeyCorp's latest quarterly results beat expectations, fueled by higher net interest income and a return to full-year profitability. The regional bank also completed a $200 million share buyback and issued $750 million in new debt, while refreshing its board. Analysts suggest these moves fine-tune the bank's strategy rather than radically alter its investment narrative.
Shares of Viavi Solutions soared over 17% after the network test and measurement company posted fiscal Q2 results that smashed analyst expectations, fueled by robust demand from data center and aerospace clients.
Despite a sharp selloff following strong quarterly results, Zscaler's fundamental growth engine—fueled by its Z-Flex platform shift and AI security demand—appears stronger than ever, presenting a potential disconnect for long-term investors.
As Alphabet prepares to report its Q4 2025 results, investors are weighing whether its soaring stock price—fueled by Gemini AI integration and cloud growth—has already priced in future success, or if more runway remains.
Despite Adtalem Global Education posting robust quarterly results with 34% EPS growth, investment firm Peregrine Asset Advisers has liquidated its entire position, raising questions about the divergence between corporate performance and investor sentiment in the education sector.
Shares of the data analytics firm jumped more than 5% following a strong quarterly report that exceeded expectations and featured ambitious growth projections for the coming year.
Following robust Q4 2025 results, Hess Midstream (HESM) is capturing investor interest with increased distributions and a leaner capital expenditure outlook. This financial discipline, set against a volatile energy backdrop, has analysts scrutinizing whether the stock's current price fully reflects its future potential.
Bitcoin struggles to regain momentum after a sharp decline, with analysts pointing to a mix of macroeconomic headwinds and stalled regulatory progress as key factors prolonging the crypto bear market.
As Alphabet prepares to report its fourth-quarter results, traders are bracing for significant stock movement. The focus is on whether strong performance in cloud and AI can justify its recent surge and sustain momentum amid heightened investor scrutiny.
Despite a dismal long-term performance, Sirius XM (SIRI) is showing curious resilience in the new year. A complex volatility skew in its options suggests traders are bracing for a potential surprise—in either direction—as the company prepares to report quarterly results.
As Palantir Technologies prepares to report Q4 results, soaring demand for its AI platform collides with sky-high valuations, leaving investors to weigh robust growth against bubble fears.
CNBC's Jim Cramer highlighted International Business Machines Corp. (IBM) as a standout AI investment with a relatively modest valuation, following a robust quarterly report that sent shares soaring.
As Reddit prepares to report its fourth-quarter results on February 5th, investors are weighing its surging user growth and lucrative data-licensing deals against a sky-high valuation and a volatile market backdrop.
Pioneer Bancorp reported a 33% surge in net income to $20.3 million for 2025, driven by loan growth and a new initiative to trade municipal bonds, as the regional bank expands its revenue streams.
U.S. equities edged higher Monday, buoyed by a rebound in semiconductor and AI infrastructure stocks, alongside a surge in rare earth companies following a new strategic initiative. Gains were tempered by falling energy shares, cryptocurrency volatility, and ongoing concerns over a partial government shutdown.
Ardelyx, Inc. (NASDAQ: ARDX) has received significant analyst upgrades, with TD Cowen and Jefferies raising price targets ahead of the company's fourth-quarter results. The optimism centers on the commercial trajectory of its flagship drug, tenapanor, for gastrointestinal and kidney conditions.
Despite a challenging 2025, Giverny Capital's latest investor letter highlights Charles Schwab as a key portfolio contributor, projecting sustained growth for the financial giant as market dynamics evolve.
Insurance brokerage giant Arthur J. Gallagher reported robust fourth-quarter profit growth, driven by resilient demand. However, Truist Securities has lowered its price target on the stock, citing valuation pressures across the property & casualty brokerage sector.
